The RiskScore constructed based on the PD-1/PD-L1 pathway influenced the degree of infiltration of multiple cells in the breast cancer tumor microenvironment and further influenced the response of breast cancer patients to immunotherapy. The gene discussed is CD274; the disease is neoplasm.